Trastuzumab-deruxtecan in Patients With Triple-negative Metastatic HER2-Low Breast Cancer: Real-world Experience in Brazil

Conditions: Breast Cancer Interventions: Drug: Trastuzumab deruxtecan Sponsors: Hospital Israelita Albert Einstein; AstraZeneca Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials